Efficacy and safety analysis of immune checkpoint inhibitors combined with chemotherapy in the treatment of advanced triple-negative breast cancer: an umbrella meta-analysis - Top-Institutions - MDSpire

Assessment of the Safety and Effectiveness of Combining Immune Checkpoint Inhibitors with Chemotherapy for Advanced Triple-Negative Breast Cancer: A Comprehensive Meta-Analysis

  • By

  • Wendi Cao

  • Qingxi Rong

  • Yingheng Song

  • Zhijun Ma

  • Qiuxia Dong

  • July 21, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #4

    European Institute of Oncology
    European Institute of Oncology

    Milan, Italy

    Key Differentiators

    • Oncology

  • #5

    Susan F. Smith Center for Women’s Cancers at Dana-Farber/Brigham and Women’s Cancer Center
    Susan F. Smith Center for Women’s Cancers at Dana-Farber/Brigham and Women’s Cancer Center

    Boston, Massachusetts

    Key Differentiators

    • Oncology

Original Source(s)

Efficacy and safety analysis of immune checkpoint inhibitors combined with chemotherapy in the treatment of advanced triple-negative breast cancer: an umbrella meta-analysis

  • by Wendi Cao, Qingxi Rong, Yingheng Song, Zhijun Ma, Qiuxia Dong

  • July 21, 2026

Related Content

Circadian rhythms in the tumor microenvironment: spatiotemporal immune regulation and chronotherapeutic opportunities

Inflammatory myofibroblastic tumour: unravelling the interplay of inflammation, kinase signalling, and therapeutic resistance

Long-term risk of gynecologic malignancies in postmenopausal women with vaginal bleeding and benign endometrial lesions: a cohort study